Wengang Wang

1.7k total citations
7 papers, 363 citations indexed

About

Wengang Wang is a scholar working on Molecular Biology, Oncology and Molecular Medicine. According to data from OpenAlex, Wengang Wang has authored 7 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Molecular Medicine. Recurrent topics in Wengang Wang's work include Curcumin's Biomedical Applications (2 papers), Nanoparticle-Based Drug Delivery (1 paper) and Autophagy in Disease and Therapy (1 paper). Wengang Wang is often cited by papers focused on Curcumin's Biomedical Applications (2 papers), Nanoparticle-Based Drug Delivery (1 paper) and Autophagy in Disease and Therapy (1 paper). Wengang Wang collaborates with scholars based in China, Macao and United States. Wengang Wang's co-authors include Xinbing Sui, Xiaying Chen, Tian Xie, Xiang Yu, Shuiping Liu, Xuemeng Han, Ting Duan, Jian-Shu Lou, Mingming Zhang and Qiujie Li and has published in prestigious journals such as Frontiers in Pharmacology, Biomedicine & Pharmacotherapy and Acta Paediatrica.

In The Last Decade

Wengang Wang

7 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wengang Wang China	6	205	81	78	46	45	7	363
Prakash Dharmalingam India	10	238 1.2×	61 0.8×	42 0.5×	53 1.2×	64 1.4×	11	417
Junlong Zhu China	11	247 1.2×	88 1.1×	54 0.7×	45 1.0×	29 0.6×	19	428
Yuting Yang China	9	182 0.9×	65 0.8×	45 0.6×	65 1.4×	29 0.6×	17	446
Lingling Si China	12	298 1.5×	94 1.2×	64 0.8×	46 1.0×	48 1.1×	17	434
Qian Zuo China	10	206 1.0×	78 1.0×	56 0.7×	72 1.6×	33 0.7×	14	352
Yuwan Zhao China	9	193 0.9×	62 0.8×	35 0.4×	52 1.1×	83 1.8×	14	334
In‐Hyoung Yang South Korea	13	229 1.1×	43 0.5×	56 0.7×	47 1.0×	65 1.4×	24	337
Nantiga Virgona Japan	18	336 1.6×	123 1.5×	63 0.8×	68 1.5×	43 1.0×	34	611
Nianzhi Chen China	12	158 0.8×	57 0.7×	40 0.5×	44 1.0×	59 1.3×	22	365
Man He China	8	216 1.1×	105 1.3×	49 0.6×	103 2.2×	35 0.8×	19	407

Countries citing papers authored by Wengang Wang

Since Specialization

Citations

This map shows the geographic impact of Wengang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wengang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wengang Wang more than expected).

Fields of papers citing papers by Wengang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wengang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wengang Wang. The network helps show where Wengang Wang may publish in the future.

Co-authorship network of co-authors of Wengang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wengang Wang. A scholar is included among the top collaborators of Wengang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wengang Wang. Wengang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wang, Wengang, et al.. (2025). GsMTx4-blocked PIEZO1 channel promotes myogenic differentiation and alleviates myofiber damage in Duchenne muscular dystrophy. Skeletal Muscle. 15(1). 13–13. 4 indexed citations

2.

Yu, Xiang, Xiaying Chen, Wengang Wang, et al.. (2021). Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation. Frontiers in Pharmacology. 12. 775506–775506. 75 indexed citations

3.

Zhai, Bingtao, Qibiao Wu, Wengang Wang, et al.. (2020). Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes. Cancer Biology and Medicine. 17(1). 60–75. 41 indexed citations

4.

Chen, Liuxi, Xingxing Huang, Wenzheng Zhang, et al.. (2020). Correlation of PD-L1 and SOCS3 Co-expression with the Prognosis of Hepatocellular Carcinoma Patients. Journal of Cancer. 11(18). 5440–5448. 18 indexed citations

5.

Chen, Xiaying, Zuyi Yang, Jiao Feng, et al.. (2020). Combination of lysine‐specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer. Cancer Medicine. 10(1). 317–324. 11 indexed citations

6.

Zhai, Bingtao, Nana Zhang, Xuemeng Han, et al.. (2019). Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review. Biomedicine & Pharmacotherapy. 114. 108812–108812. 195 indexed citations

7.

Goetzl, Edward J., et al.. (2007). Sphingosine 1‐phosphate as an intracellular messenger and extracellular mediator in immunity. Acta Paediatrica. 96(s455). 49–52. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact